Colorectal Cancer

Updates from the American Society of Clinical Oncology meetings on genitourinary and gastrointestinal cancers.

Regorafenib shows to extend survival in metastatic colorectal cancer.

Ginger has been investigated for its anti-nausea proper ties, and it’s back in the news as a possible preventive for colon cancer.

A new study published in The Lancet shows that one group could reduce their risk of colorectal cancer from taking the pill on a daily basis.

Recent studies link vitamin D and folate intake to colon cancer risk reduction.

ColoPrint gene assay can help guide treatment options for some colorectal patients, study shows.

Widespread genetic testing of Lynch syndrome is cost-efficient and reduces the risk of colorectal cancer.

A growing population of patients have emerged: long-term metastatic cancer survivors.

The latest in cancer prevention, diagnosis, and treatment.

Early-stage colorectal cancer patients may benefit from a new test that predicts their risk of recurrence.

Chronic inflammation causes cancer. Find out how and what's being done about it.

What does Medicare cover when it comes to screening for colorectal cancer?

Despite the gains noted in the overall number of Medicare patients undergoing colonoscopy, researchers continue to see differences in colorectal cancer screening rates among certain groups, particularly minorities.

Newer targets found on cancer cells are providing scientists the ammunition to better treat cancer.

Adding Avastin (bevacizumab) to standard chemotherapy after surgery failed to extend the time early-stage colon cancer patients were free of recurrence.

For the first time, a test can predict which patients with stage 2 colon cancer are more likely to have a recurrence.

Gene testing now recommended before colon cancer treatment

Treatment updates from the 2009 ASCO Gastrointestinal Cancers Symposium.

New colorectal cancer screening gets high marks.

Predicting drug response in colorectal cancer.

KRAS gene mutations are detected in various cancers, including colorectal.

A timeline of KRAS research.

Issues after surgery can be taxing for patient and caregiver.

Colorectal cancer survivors take their message to Congress.

Fighting colon cancer was only part of the battle; this survivor then had to learn how, and what, to eat all over again.